Albany, New York, USA (PRWEB) October 21, 2013
Apoptosis is the process of programmed cell death that occurs due to biochemical events. There are a variety of changes, also referred to as morphology, that occur in a cell leading to its death. These changes could be cell shrinkage, fragmentation, blebbing, and chromatin condensation. Approximately 50 billion to 60 billion cells die each day due to apoptosis in an average human adult; however, insufficient apoptosis may lead to cancer. Apoptosis research has been on the increase since the early 1990s, with a focus on cancer treatment. This represents one of the emerging markets in the pharmaceutical sector, which is expected to grow over the next decade.
Browse the full report with complete TOC at http://www.transparencymarketresearch.com/apoptosis-market.html
The market can be segmented as follows,
First generation indirect apoptogens
Second generation indirect apoptogens
First generation indirect apoptogens deal with the dependence of drugs such as cytotoxics, which partly rely on apoptosis for effectiveness. Second generation indirect apoptogens are recently introduced drugs which do not rely on apoptosis for their working. However, direct apoptogens have apoptosis related molecular targets, and they are the inducers for apoptosis.
Increased number of cancer cases, chronic diseases and patients, followed by growing demand for healthcare services, and increased disposable incomes are the major drivers for this market. High investment required in projects related to apoptosis for infrastructure and research personnel are the restraints for this market. A challenge for researchers is the deployment of an improved drug which will detect and cure cancer using apoptosis.
Currently, North America is leading the market with various research projects for utilizing apoptosis in cancer treatment, followed by Europe and Rest of the World. Some of the major players in this industry include pFizer Inc, Novartis Ltd., EntreMed Inc., ApiCept Corporation, ISIS Pharmaceuticals, Inc., Pharmacyclics Inc., TopoTarget, Xigen SA, Zentaris GmBH , Amgen Inc., Celgene Corporation, Bioniche Life Sciences Inc., Exelexis Inc., EpiCept Corporation, Genta, Inc., Chroma Therapeutics, ApopLogic Pharmaceuticals, and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Related Report : Wound Treatment Market